Maduell F, Sánchez-Alcaraz A, Sigüenza F, Caridad A, Sangrador G
Department of Pharmaceutical Services, Lluis Alcanyis Hospital, Xàtiva, Spain.
J Clin Pharm Ther. 1993 Feb;18(1):59-62. doi: 10.1111/j.1365-2710.1993.tb00568.x.
Recent reports suggest that cyclosporin A is beneficial in inducing remission of idiopathic nephrotic syndrome. Nephrotic syndrome is seen in 10-30% of patients with rapidly progressive glomerulonephritis. We report a case of a 69-year-old man with nephrotic syndrome, associated with idiopathic rapidly progressive glomerulonephritis, who was treated initially with corticosteroid and cyclophosphamide. Three months later he developed thrombophlebitis and leucopenia and cyclophosphamide was suspended. Relapse of nephrotic syndrome associated with rapidly progressive glomerulonephritis developed and therapy with cyclosporin A was used with a good response.
近期报告表明,环孢素A有助于诱导特发性肾病综合征缓解。在10%至30%的快速进展性肾小球肾炎患者中可见肾病综合征。我们报告一例69岁男性肾病综合征患者,其与特发性快速进展性肾小球肾炎相关,最初接受皮质类固醇和环磷酰胺治疗。三个月后,他出现了血栓性静脉炎和白细胞减少症,环磷酰胺停用。与快速进展性肾小球肾炎相关的肾病综合征复发,随后使用环孢素A治疗,效果良好。